WO2001053830A3 - Methode diagnostique - Google Patents

Methode diagnostique Download PDF

Info

Publication number
WO2001053830A3
WO2001053830A3 PCT/GB2001/000173 GB0100173W WO0153830A3 WO 2001053830 A3 WO2001053830 A3 WO 2001053830A3 GB 0100173 W GB0100173 W GB 0100173W WO 0153830 A3 WO0153830 A3 WO 0153830A3
Authority
WO
WIPO (PCT)
Prior art keywords
haematocrit
blood cell
cell count
haemoglobin
reg
Prior art date
Application number
PCT/GB2001/000173
Other languages
English (en)
Other versions
WO2001053830A2 (fr
Inventor
Toby Grahame Knowles
Original Assignee
Univ Bristol
Toby Grahame Knowles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bristol, Toby Grahame Knowles filed Critical Univ Bristol
Priority to EP01901248A priority Critical patent/EP1248951A2/fr
Priority to AU26908/01A priority patent/AU771538B2/en
Publication of WO2001053830A2 publication Critical patent/WO2001053830A2/fr
Publication of WO2001053830A3 publication Critical patent/WO2001053830A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Méthode de prédiction de la capacité de résistance d'un animal contre la maladie, en particulier, une maladie transmissible à un stade précoce de sa vie. L'invention concerne également des procédés servant à prédire le potentiel de croissance en fonction de niveaux de mesure de certaines variables du spécimen sanguin.
PCT/GB2001/000173 2000-01-17 2001-01-17 Methode diagnostique WO2001053830A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01901248A EP1248951A2 (fr) 2000-01-17 2001-01-17 Methode diagnostique
AU26908/01A AU771538B2 (en) 2000-01-17 2001-01-17 Diagnostic method involving haemoglobin, haematocrit or red blood cell count

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0001058.7 2000-01-17
GB0001058A GB0001058D0 (en) 2000-01-17 2000-01-17 Diagnostic method

Publications (2)

Publication Number Publication Date
WO2001053830A2 WO2001053830A2 (fr) 2001-07-26
WO2001053830A3 true WO2001053830A3 (fr) 2001-12-27

Family

ID=9883860

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/000173 WO2001053830A2 (fr) 2000-01-17 2001-01-17 Methode diagnostique

Country Status (4)

Country Link
EP (1) EP1248951A2 (fr)
AU (1) AU771538B2 (fr)
GB (1) GB0001058D0 (fr)
WO (1) WO2001053830A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115459A2 (fr) * 1983-01-26 1984-08-08 University Of Medicine And Dentistry Of New Jersey Prédiction hématologique de la Sepsis et des autres étapes de maladie
RU1772746C (ru) * 1990-07-10 1992-10-30 Смоленский государственный медицинский институт Способ исследовани динамики отека головного мозга
US5506145A (en) * 1994-12-02 1996-04-09 Bull; Brian S. Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements
RU2123697C1 (ru) * 1996-08-05 1998-12-20 Алтайский государственный медицинский университет Способ прогнозирования исходов тяжелых воспалительных заболеваний челюстно-лицевой области

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115459A2 (fr) * 1983-01-26 1984-08-08 University Of Medicine And Dentistry Of New Jersey Prédiction hématologique de la Sepsis et des autres étapes de maladie
RU1772746C (ru) * 1990-07-10 1992-10-30 Смоленский государственный медицинский институт Способ исследовани динамики отека головного мозга
US5506145A (en) * 1994-12-02 1996-04-09 Bull; Brian S. Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements
RU2123697C1 (ru) * 1996-08-05 1998-12-20 Алтайский государственный медицинский университет Способ прогнозирования исходов тяжелых воспалительных заболеваний челюстно-лицевой области

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AN 1993-350047, XP002164999 *
DATABASE WPI Derwent World Patents Index; AN 2000-221783, XP002165000 *
MARTIN S W ET AL: "THE RELATIONSHIP OF HEMATOLOGY AND SERUM CHEMISTRY PARAMETERS TO TREATMENT FOR RESPIRATORY DISEASE AND WEIGHT GAIN IN ONTARIO CANADA FEEDLOT CALVES", CANADIAN JOURNAL OF VETERINARY RESEARCH, vol. 51, no. 4, 1987, pages 499 - 505, XP000998525, ISSN: 0830-9000 *

Also Published As

Publication number Publication date
GB0001058D0 (en) 2000-03-08
EP1248951A2 (fr) 2002-10-16
AU2690801A (en) 2001-07-31
AU771538B2 (en) 2004-03-25
WO2001053830A2 (fr) 2001-07-26

Similar Documents

Publication Publication Date Title
WO2008028489A3 (fr) Surveillance immunologique sur la base de ip-10
WO2005114190A3 (fr) Procedes pour identifier des marqueurs biologiques
WO2003009806A3 (fr) Methodes d'evaluation d'affections pathologiques utilisant un arn extracellulaire
WO2004112572A3 (fr) Surveillance de maladies immunologiques, hematologiques et inflammatoires
WO2003040406A3 (fr) Surveillance d'une plaie
WO2006071247A3 (fr) Analyses diagnostiques comprenant des analyses immunologiques sur membrane multiplexees faisant intervenir des points quantiques
WO2006085984A3 (fr) Biocapteurs de cellules immunes et procedes d'utilisation
WO2004042346A3 (fr) Methodes et compositions permettant de diagnostiquer et de surveiller le rejet d'un greffon
WO2001040517A3 (fr) Evaluation et prediction cliniques obtenues par analyse d"expression genique
WO2004044554A3 (fr) Diagnostic pour la septicemie ou le sirs au moyen de profils de biomarqueurs
WO2006025028A3 (fr) Nouvelle methode de classification des globules sanguins servant de base a des activites therapeutiques et preventives sur mesure
PT1283907E (pt) Metodo para o diagnostico de cancros
WO2006059252A3 (fr) Procedes et compositions fluorees pour le traitement de maladies associees aux amyloides
WO2003087760A3 (fr) Procedes de detection d'activite de signalisation bcr-abl dans des tissus a l'aide d'anticorps phospho-specifiques
WO2004015420A8 (fr) Procede de diagnostic de sclerose en plaques
WO2001053830A3 (fr) Methode diagnostique
EP1247584A3 (fr) Centrifugeuse avec capteur
WO2003048734A3 (fr) Detection d'arn de metalloproteinase matricielle dans du plasma et du serum
WO2007012937A3 (fr) Methode de diagnostic du gliome avec distinction entre types progressif et de novo
WO2003068958A1 (fr) Procede d'analyse d'un acide nucleique specifiant un gene presentant une modification de son niveau d'expression liee a la schizophrenie
DK1393078T3 (da) Fremgangsmåder til diagnosticering in vitro eller til overvågning af en sygdom involverende en inflammatorisk reaktion
WO2008002911A3 (fr) Métabolites d'urate utilisés en tant que marqueurs diagnostiques pour une maladie cardiovasculaire et rénale
WO2004098391A3 (fr) Methodes de detection d'infections a parvovirus
AU2003294932A1 (en) Method for the detection of cancer
WO2000011215A3 (fr) Procede de depistage diagnostique

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001901248

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 520356

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 26908/01

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2001901248

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 520356

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 26908/01

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 520356

Country of ref document: NZ

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001901248

Country of ref document: EP